European Archives - Page 494 of 1423 - European Medical Journal

New Algorithm Uncovers Hidden Obesity Subtypes Linked to Severe Health Risks

Obesity, defined as abnormal or excessive fat accumulation, has more than doubled among adults since 1990

New Model Boosts Personalised Care for Severe Psoriasis

A recent study from 12 hospitals across China has shed new light on personalised care for plaque psoriasis.

Therapeutic Advances in GI Cancers: Immuno-Oncology and Beyond

At the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, the latest advancements in immunotherapy for…

Onc Now: Episode 4: The Role of RNA in Oncology – Part 1

This week, Jonathan Sackier is joined by Sarah Blagden, a pioneer of experimental oncology research, and CEO of RNA Guardian Ltd, a biotechnology company dedicated to identifying early cancer biomarkers.

Early Intervention with TAVR Improves Outcomes in Asymptomatic Severe Aortic Stenosis

Early transcatheter aortic-valve replacement is more effective than clinical surveillance in reducing adverse outcomes in patients with asymptomatic severe aortic stenosis.

AZ's new obesity pill shows promise, enters phase II

AstraZeneca’s new weight-loss pill, licensed from China’s Eccogene last year, has shown initial promise in early-stage trials.

Long-Term Ventilation Linked to Improved Survival in COPD-OSA Patients

Long-term PAP therapy may boost survival in patients with COPD and OSA, highlighting potential benefits of early diagnosis and proactive respiratory management.

AI Method Shows Promise in Predicting Prostate Cancer Prognosis

Using advanced MRI imaging, an AI segmentation algorithm was developed and trained to delineate specific tumour lesions.

SGLT2 Inhibitors Reduce Cardiovascular Risks in Patients with Type 2 Diabetes

New research has revealed that SGLT2is are associated with an 18% reduction in total cardiovascular disease risk compared with DPP4is.

Novel CAR-T Approach Shows Promise Against Paediatric AML

Recent research presents a groundbreaking CAR-T therapy for paediatric acute myeloid leukaemia, addressing the challenges posed by antigen variability.